IN2012MN02606A - - Google Patents
Info
- Publication number
- IN2012MN02606A IN2012MN02606A IN2606MUN2012A IN2012MN02606A IN 2012MN02606 A IN2012MN02606 A IN 2012MN02606A IN 2606MUN2012 A IN2606MUN2012 A IN 2606MUN2012A IN 2012MN02606 A IN2012MN02606 A IN 2012MN02606A
- Authority
- IN
- India
- Prior art keywords
- volatile solvent
- formulation
- poly
- system including
- solvent system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33215710P | 2010-05-06 | 2010-05-06 | |
| PCT/US2011/035216 WO2011140236A2 (en) | 2010-05-06 | 2011-05-04 | Triamcinolone acetonide formulations for treating dermatitis and psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012MN02606A true IN2012MN02606A (de) | 2015-05-22 |
Family
ID=44904454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2606MUN2012 IN2012MN02606A (de) | 2010-05-06 | 2011-05-04 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130338127A1 (de) |
| EP (1) | EP2566456A4 (de) |
| JP (1) | JP2013528590A (de) |
| CN (1) | CN102970974B (de) |
| AU (1) | AU2011248162A1 (de) |
| BR (1) | BR112012028267A2 (de) |
| CA (1) | CA2798316A1 (de) |
| IN (1) | IN2012MN02606A (de) |
| WO (1) | WO2011140236A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
| US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107161A (en) * | 1972-05-13 | 1978-08-15 | J. Uriach & Cia. S.A. | Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate) |
| JPS62263120A (ja) * | 1986-05-09 | 1987-11-16 | Sekisui Chem Co Ltd | 貼付剤 |
| US20040141925A1 (en) * | 1998-11-12 | 2004-07-22 | Elan Pharma International Ltd. | Novel triamcinolone compositions |
| US6830758B2 (en) * | 2001-04-02 | 2004-12-14 | Lectec Corporation | Psoriasis patch |
| WO2003030823A2 (en) * | 2001-10-05 | 2003-04-17 | Combinatorx, Incorporated | Combinations for the treatment of immunoinflammatory disorders |
| KR100843001B1 (ko) * | 2002-01-16 | 2008-07-01 | 동화약품공업주식회사 | 구강점막 부착형 필름제제 |
| US20030185915A1 (en) * | 2002-03-28 | 2003-10-02 | Jaime Carlo | Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor |
| TR200201556A2 (tr) * | 2002-06-12 | 2004-01-21 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve nonsteroidal antienflamatuar içeren farmasötik bileşim |
| US8741333B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
| WO2007070695A2 (en) * | 2005-12-14 | 2007-06-21 | Zars, Inc. | Flux-enabling compositions and methods for dermal delivery of drugs |
-
2011
- 2011-05-04 IN IN2606MUN2012 patent/IN2012MN02606A/en unknown
- 2011-05-04 EP EP11778272.2A patent/EP2566456A4/de not_active Withdrawn
- 2011-05-04 AU AU2011248162A patent/AU2011248162A1/en not_active Abandoned
- 2011-05-04 CN CN201180033370.XA patent/CN102970974B/zh not_active Expired - Fee Related
- 2011-05-04 US US13/695,669 patent/US20130338127A1/en not_active Abandoned
- 2011-05-04 CA CA2798316A patent/CA2798316A1/en not_active Abandoned
- 2011-05-04 BR BR112012028267A patent/BR112012028267A2/pt not_active IP Right Cessation
- 2011-05-04 WO PCT/US2011/035216 patent/WO2011140236A2/en active Application Filing
- 2011-05-04 JP JP2013509226A patent/JP2013528590A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN102970974B (zh) | 2015-03-04 |
| WO2011140236A3 (en) | 2012-03-01 |
| AU2011248162A1 (en) | 2012-12-20 |
| CN102970974A (zh) | 2013-03-13 |
| CA2798316A1 (en) | 2011-11-10 |
| EP2566456A2 (de) | 2013-03-13 |
| US20130338127A1 (en) | 2013-12-19 |
| BR112012028267A2 (pt) | 2016-11-01 |
| EP2566456A4 (de) | 2013-09-25 |
| WO2011140236A2 (en) | 2011-11-10 |
| JP2013528590A (ja) | 2013-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201492011A1 (ru) | Безводные фармацевтические составы для местного применения | |
| MY177912A (en) | Vegf neutralizing prodrugs for the treatment of ocular conditions | |
| CR20140365A (es) | Compuestos de carbamato y preparación y uso de los mismos | |
| WO2011103202A3 (en) | Androgen receptor modulators and uses thereof | |
| CO7160098A2 (es) | Suministro de fármaco biodegradable para las composiciones hidrofóbicas | |
| SG10201808743VA (en) | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa | |
| WO2014011590A3 (en) | Composition and method for treatment of depression and psychosis in humans | |
| PH12014502095A1 (en) | Estrogen receptor modulators and uses thereof | |
| CZ308492B6 (cs) | Kosmetická kompozice na bázi kyseliny hyaluronové, způsob její přípravy a použití | |
| BR112014030386A8 (pt) | Compostos e composições para modular a atividade de egfr | |
| PH12014501351B1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
| BR112014029206A2 (pt) | pós hemostáticos de celulose regenerada oxidada e métodos para fabricação dos mesmos | |
| BR112013003671A2 (pt) | composições e métodos para melhorar os benefícios terapêuticos de compostos químicos administyrados sub-otimamente incluindo hexitóis substituídos tais como dianidrogalactitol e diacetildianidrogalactiol | |
| EA201691808A1 (ru) | Кортикостероидные композиции для местного применения | |
| BR112017004115A2 (pt) | composição para cuidados pessoais, e, métodos para aumento da viscosidade e para preparação de uma composição para cuidados pessoais. | |
| UY32944A (es) | Compuestos poliméricos de ésteres silil benzoicos, sus usos y composiciones | |
| DOP2015000303A (es) | Letermovir amorfo y formulaciones farmacéuticas sólidas del mismo para administración por vía oral | |
| MX2015008021A (es) | Composiciones y metodos para administracion transdermica de hormonas y otros agentes medicos. | |
| MX361349B (es) | Moduladores del receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dérmicas. | |
| MX2016008136A (es) | Formulaciones de giberelina con baja cantidad de productos quimicos organicos volatiles. | |
| EP2515912A4 (de) | Pharmazeutische zusammensetzung mit vitamin-d-analogon und colöser-tensid-mischung | |
| IN2012MN02606A (de) | ||
| MX2016000116A (es) | Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana. | |
| EP3525757A4 (de) | Verfahren zur verringerung der dermalen absorption unter verwendung von zusammensetzungen mit siloxanpolymer | |
| CL2016002956A1 (es) | Procedimiento de la preparación de un polímero fotoprotector progresivo de organosilicio; composición cosmética o dermatológica; uso como protector de la radiación ultravioleta. |